Literature DB >> 27451306

Pituitary Dysfunction: A Case Series of Immune Checkpoint Inhibitor-Related Hypophysitis in an Emergency Department.

Adam H Miller1, Patricia Brock1, Sai-Ching Jim Yeung1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27451306     DOI： 10.1016/j.annemergmed.2016.03.048

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  5 in total

Review 1.  Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Authors:  Meng H Tan; Ravi Iyengar; Kara Mizokami-Stout; Sarah Yentz; Mark P MacEachern; Li Yan Shen; Bruce Redman; Roma Gianchandani
Journal:  Clin Diabetes Endocrinol       Date:  2019-01-22

Review 2.  The side effects of immune checkpoint inhibitor therapy on the endocrine system.

Authors:  Itivrita Goyal; Manu Raj Pandey; Rajeev Sharma; Ajay Chaudhuri; Paresh Dandona
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 5.274

3.  Refractory hypotension due to Nivolumab-induced adrenal insufficiency.

Authors:  Yoshiaki Tsukizawa; Keisuke Kondo; Toshihisa Ichiba; Hiroshi Naito; Kazuhito Mizuki; Ken Masuda
Journal:  Nagoya J Med Sci       Date:  2018-05       Impact factor: 1.131

4.  Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population.

Authors:  Khor Zhong Wei; Mark Baxter; Richard Casasola
Journal:  Melanoma Manag       Date:  2019-04-15

Review 5.  Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review.

Authors:  Maria Stelmachowska-Banaś; Izabella Czajka-Oraniec
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.